Clinical Trial: HWS116 Monotherapy in Patients With Advanced Solid Tumors

U.S., Feb. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07413328) titled 'HWS116 Monotherapy in Patients With Advanced Solid Tumors' on Feb. 09.

Brief Summary: This is a Phase I open-label study that will evaluate the safety, tolerability, pharmacokinetics, and preliminary efficacy of HWS116 monotherapy in patients with advanced solid tumors.

Study Start Date: Feb. 04

Study Type: INTERVENTIONAL

Condition: Advanced Solid Tumors

Intervention: DRUG: HWS116 Injection

Administered intravenous infusion at pre-specified doses every two weeks.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Wuhan Humanwell Innovative Drug Research and Development Center Limited Company

Published by HT Digital Content Se...